-+ 0.00%
-+ 0.00%
-+ 0.00%

ULTRAGENYX PHARMA PLUNGES 45%, HITS ALL-TIME LOW AFTER CO'S RARE DISEASE DRUG FAILS TO MEET MAIN GOAL IN LATE-STAGE TRIAL

Reuters·09/03/2026 13:50:14

Please log in to view news